Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France
NCT02347865
·
clinicaltrials.gov ↗
COMPLETED
Status
777
Enrollment
INDUSTRY
Sponsor class
Conditions
Post Menopausal Osteoporosis
Interventions
DRUG:
AMG 162 - Prolia
DRUG:
AMG 162 - Prolia
Sponsor
Amgen